Arrhythmia after chemotherapy  clinical observation

Akhmedova N.A, Kurbankulova A.A.

dc.contributor.author	Akhmedova N.A, Kurbankulova A.A.
dc.date.accessioned	2024-01-24T17:24:32Z
dc.date.available	2024-01-24T17:24:32Z
dc.date.issued	2023-12-27
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10690
dc.description.abstract	Acute cardiotoxicity of antitumor drugs can be manifested by various cardiac arrhythmias and conduction disturbances for up to 2 weeks. after their application. We present a clinical observation of a patient with Hodgkin's lymphoma treated with cisplatin and cytarabine. The next day after the end of chemotherapy, the first atrial fibrillation was noted	en_US
dc.language.iso	en_US	en_US
dc.publisher	Modern Scientific Research International Scientific Journal 2023 Vol1 Issue 4	en_US
dc.relation.ispartofseries	Journal 2023 Vol1 Issue 4;
dc.subject	chemotherapy, acute cardiotoxicity, cardiac arrhythmias	en_US
dc.title	Arrhythmia after chemotherapy clinical observation	en_US
dc.type	Article	en_US